A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing-Reference-Cited by-同舟云学术

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing

Published:2023-04 Issue:2 Volume:8 Page:100881
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Paiella S.,Azzolina D.,Gregori D.,Malleo G.,Golan T.,Simeone D.M.,Davis M.B.,Vacca P.G.,Crovetto A.,Bassi C.,Salvia R.,Biankin A.V.,Casolino R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference110 articles.

1. Precision medicine for BRCA/PALB2-mutated pancreatic cancer and emerging strategies to improve therapeutic responses to PARP inhibition;Principe;Cancers (Basel),2022

2. ICGC-ARGO precision medicine: familial matters in pancreatic cancer;Milella;Lancet Oncol,2022

3. Germline aberrations in pancreatic cancer: implications for clinical care;Casolino;Cancers (Basel),2022

4. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer;Golan;N Engl J Med,2019

5. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Tempero;J Natl Compr Canc Netw,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer;BMC Cancer;2024-08-12

2. Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma;JCO Precision Oncology;2024-08

3. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma;JCO Oncology Practice;2024-08

4. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-07-20

5. Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022;JCO Precision Oncology;2024-07